News and Announcements

GSK's Arexy receives EU green light

By Iain Gilbert

Date: Friday 12 Dec 2025

(Sharecast News) - GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had recommended expanding the use of Arexy, its RSV vaccine, to all adults aged 18 and over.
The European Commission was expected to deliver its final decision in February 2026 and, if...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page